Mark J. Bishton, Rodney J. Hicks, David A. Westerman, Miles H. Prince, Max Wolf and John F. Seymour (2008) “A prospective study of the separate predictive capabilities of 18[F]-FDG-PET and molecular response in patients with relapsed indolent non-Hodgkin’s lymphoma following treatment with iodine-131-rituximab radio-immunotherapy”, Haematologica. Pavia, Italy, 93(5), pp. 789-790. doi: 10.3324/haematol.12253.